The use of vitamin D for patients with inflammatory bowel diseases: A systematic review
As vitamin D (VD) plays an essential role in inflammatory bowel diseases (IBD), this systematic review aimed to update the participation of this vitamin in the prevention or remission of these diseases. This review has included studies in MEDLINE–PubMed, EMBASE, and Cochrane databases. The authors h...
Gespeichert in:
| Veröffentlicht in: | International journal for vitamin and nutrition research 2024-02, Vol.94 (1), p.54-70 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 70 |
|---|---|
| container_issue | 1 |
| container_start_page | 54 |
| container_title | International journal for vitamin and nutrition research |
| container_volume | 94 |
| creator | Matias, Júlia Novaes Lima, Vinícius Marinho Nutels, Giovanna Soares Laurindo, Lucas Fornari Barbalho, Sandra Maria de Alvares Goulart, Ricardo Araújo, Adriano Cressoni Suzuki, Rodrigo Buzinaro Guiguer, Elen Landgraf |
| description | As vitamin D (VD) plays an essential role in inflammatory bowel diseases (IBD), this systematic review aimed to update the participation of this vitamin in the prevention or remission of these diseases. This review has included studies in MEDLINE–PubMed, EMBASE, and Cochrane databases. The authors have followed PRISMA (Preferred Reporting Items for a Systematic Review and Meta-analysis) guidelines. According to the inclusion and exclusion criteria, twenty-two randomized clinical trials were selected. In total, 1,209 patients were included in this systematic review: 1034 received only VD and 175 received VD in combination with calcium. The average doses of VD supplementation were from oral 400 IU daily to 10,000 IU per kilogram of body weight. Single injection of 300,000 IU of VD was also used. Several studies have shown the crucial role that VD plays in the therapeutic approach of IBD due to its effects on the immune system. It effectively decreased inflammatory cytokines such as TNF-α and IFN-γ (p |
| doi_str_mv | 10.1024/0300-9831/a000764 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1024_0300_9831_a000764</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1024_0300_9831_a000764</sourcerecordid><originalsourceid>FETCH-LOGICAL-c197t-a363b8162d9b537edbbe512964cd4dcb3b52d62d4a5347d0cf72a378fc9e553</originalsourceid><addsrcrecordid>eNo9kMtKAzEYRoMoWKsP4C4vMPbPfWap9QoFF3YfcqWRuZQkWvr2OlhcfYsDH5yD0C2BOwKUr4ABNF3LyMoAgJL8DC2IlLyhLSXnaPHPL9FVKZ8ATJGWL9DDdhfwVwl4ivg7VTOkET_iOGW8NzWFsRZ8SHWH0xh7MwymTvmI7XQIPfapBFNCuUYX0fQl3Jx2iT6en7br12bz_vK2vt80jnSqNoZJZlsiqe-sYCp4a4MgtJPcee6dZVZQ_0u5EYwrDy4qaphqo-uCEGyJyN-ry1MpOUS9z2kw-agJ6DmBnhX1rKhPCdgPWYxPAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The use of vitamin D for patients with inflammatory bowel diseases: A systematic review</title><source>Alma/SFX Local Collection</source><creator>Matias, Júlia Novaes ; Lima, Vinícius Marinho ; Nutels, Giovanna Soares ; Laurindo, Lucas Fornari ; Barbalho, Sandra Maria ; de Alvares Goulart, Ricardo ; Araújo, Adriano Cressoni ; Suzuki, Rodrigo Buzinaro ; Guiguer, Elen Landgraf</creator><creatorcontrib>Matias, Júlia Novaes ; Lima, Vinícius Marinho ; Nutels, Giovanna Soares ; Laurindo, Lucas Fornari ; Barbalho, Sandra Maria ; de Alvares Goulart, Ricardo ; Araújo, Adriano Cressoni ; Suzuki, Rodrigo Buzinaro ; Guiguer, Elen Landgraf</creatorcontrib><description>As vitamin D (VD) plays an essential role in inflammatory bowel diseases (IBD), this systematic review aimed to update the participation of this vitamin in the prevention or remission of these diseases. This review has included studies in MEDLINE–PubMed, EMBASE, and Cochrane databases. The authors have followed PRISMA (Preferred Reporting Items for a Systematic Review and Meta-analysis) guidelines. According to the inclusion and exclusion criteria, twenty-two randomized clinical trials were selected. In total, 1,209 patients were included in this systematic review: 1034 received only VD and 175 received VD in combination with calcium. The average doses of VD supplementation were from oral 400 IU daily to 10,000 IU per kilogram of body weight. Single injection of 300,000 IU of VD was also used. Several studies have shown the crucial role that VD plays in the therapeutic approach of IBD due to its effects on the immune system. It effectively decreased inflammatory cytokines such as TNF-α and IFN-γ (p<0.05) and provided a reduction in disease activity assessed through different scores such as Crohn’s Disease Activity Index (CDAI) (p<0.05) and Ulcerative Colitis Disease Activity Index (UCDAI) (p<0.05). Unfortunately, the available clinical trials are not standardized for of doses and routes of administration. Existing meta-analyses are biased because they compare studies using different doses or treatments in combination with different drugs or supplements such as calcium. Even though VD has crucial effects on inflammatory processes, there is still a need for standardized studies to establish how the supplementation should be performed and the doses to be administered.</description><identifier>ISSN: 0300-9831</identifier><identifier>EISSN: 1664-2821</identifier><identifier>DOI: 10.1024/0300-9831/a000764</identifier><language>eng</language><ispartof>International journal for vitamin and nutrition research, 2024-02, Vol.94 (1), p.54-70</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c197t-a363b8162d9b537edbbe512964cd4dcb3b52d62d4a5347d0cf72a378fc9e553</cites><orcidid>0000-0003-3159-0982 ; 0000-0001-6006-1321 ; 0000-0002-9930-9694 ; 0000-0002-5035-876X ; 0000-0002-5716-2444 ; 0000-0003-2445-0332</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Matias, Júlia Novaes</creatorcontrib><creatorcontrib>Lima, Vinícius Marinho</creatorcontrib><creatorcontrib>Nutels, Giovanna Soares</creatorcontrib><creatorcontrib>Laurindo, Lucas Fornari</creatorcontrib><creatorcontrib>Barbalho, Sandra Maria</creatorcontrib><creatorcontrib>de Alvares Goulart, Ricardo</creatorcontrib><creatorcontrib>Araújo, Adriano Cressoni</creatorcontrib><creatorcontrib>Suzuki, Rodrigo Buzinaro</creatorcontrib><creatorcontrib>Guiguer, Elen Landgraf</creatorcontrib><title>The use of vitamin D for patients with inflammatory bowel diseases: A systematic review</title><title>International journal for vitamin and nutrition research</title><description>As vitamin D (VD) plays an essential role in inflammatory bowel diseases (IBD), this systematic review aimed to update the participation of this vitamin in the prevention or remission of these diseases. This review has included studies in MEDLINE–PubMed, EMBASE, and Cochrane databases. The authors have followed PRISMA (Preferred Reporting Items for a Systematic Review and Meta-analysis) guidelines. According to the inclusion and exclusion criteria, twenty-two randomized clinical trials were selected. In total, 1,209 patients were included in this systematic review: 1034 received only VD and 175 received VD in combination with calcium. The average doses of VD supplementation were from oral 400 IU daily to 10,000 IU per kilogram of body weight. Single injection of 300,000 IU of VD was also used. Several studies have shown the crucial role that VD plays in the therapeutic approach of IBD due to its effects on the immune system. It effectively decreased inflammatory cytokines such as TNF-α and IFN-γ (p<0.05) and provided a reduction in disease activity assessed through different scores such as Crohn’s Disease Activity Index (CDAI) (p<0.05) and Ulcerative Colitis Disease Activity Index (UCDAI) (p<0.05). Unfortunately, the available clinical trials are not standardized for of doses and routes of administration. Existing meta-analyses are biased because they compare studies using different doses or treatments in combination with different drugs or supplements such as calcium. Even though VD has crucial effects on inflammatory processes, there is still a need for standardized studies to establish how the supplementation should be performed and the doses to be administered.</description><issn>0300-9831</issn><issn>1664-2821</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kMtKAzEYRoMoWKsP4C4vMPbPfWap9QoFF3YfcqWRuZQkWvr2OlhcfYsDH5yD0C2BOwKUr4ABNF3LyMoAgJL8DC2IlLyhLSXnaPHPL9FVKZ8ATJGWL9DDdhfwVwl4ivg7VTOkET_iOGW8NzWFsRZ8SHWH0xh7MwymTvmI7XQIPfapBFNCuUYX0fQl3Jx2iT6en7br12bz_vK2vt80jnSqNoZJZlsiqe-sYCp4a4MgtJPcee6dZVZQ_0u5EYwrDy4qaphqo-uCEGyJyN-ry1MpOUS9z2kw-agJ6DmBnhX1rKhPCdgPWYxPAA</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>Matias, Júlia Novaes</creator><creator>Lima, Vinícius Marinho</creator><creator>Nutels, Giovanna Soares</creator><creator>Laurindo, Lucas Fornari</creator><creator>Barbalho, Sandra Maria</creator><creator>de Alvares Goulart, Ricardo</creator><creator>Araújo, Adriano Cressoni</creator><creator>Suzuki, Rodrigo Buzinaro</creator><creator>Guiguer, Elen Landgraf</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-3159-0982</orcidid><orcidid>https://orcid.org/0000-0001-6006-1321</orcidid><orcidid>https://orcid.org/0000-0002-9930-9694</orcidid><orcidid>https://orcid.org/0000-0002-5035-876X</orcidid><orcidid>https://orcid.org/0000-0002-5716-2444</orcidid><orcidid>https://orcid.org/0000-0003-2445-0332</orcidid></search><sort><creationdate>202402</creationdate><title>The use of vitamin D for patients with inflammatory bowel diseases</title><author>Matias, Júlia Novaes ; Lima, Vinícius Marinho ; Nutels, Giovanna Soares ; Laurindo, Lucas Fornari ; Barbalho, Sandra Maria ; de Alvares Goulart, Ricardo ; Araújo, Adriano Cressoni ; Suzuki, Rodrigo Buzinaro ; Guiguer, Elen Landgraf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c197t-a363b8162d9b537edbbe512964cd4dcb3b52d62d4a5347d0cf72a378fc9e553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matias, Júlia Novaes</creatorcontrib><creatorcontrib>Lima, Vinícius Marinho</creatorcontrib><creatorcontrib>Nutels, Giovanna Soares</creatorcontrib><creatorcontrib>Laurindo, Lucas Fornari</creatorcontrib><creatorcontrib>Barbalho, Sandra Maria</creatorcontrib><creatorcontrib>de Alvares Goulart, Ricardo</creatorcontrib><creatorcontrib>Araújo, Adriano Cressoni</creatorcontrib><creatorcontrib>Suzuki, Rodrigo Buzinaro</creatorcontrib><creatorcontrib>Guiguer, Elen Landgraf</creatorcontrib><collection>CrossRef</collection><jtitle>International journal for vitamin and nutrition research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matias, Júlia Novaes</au><au>Lima, Vinícius Marinho</au><au>Nutels, Giovanna Soares</au><au>Laurindo, Lucas Fornari</au><au>Barbalho, Sandra Maria</au><au>de Alvares Goulart, Ricardo</au><au>Araújo, Adriano Cressoni</au><au>Suzuki, Rodrigo Buzinaro</au><au>Guiguer, Elen Landgraf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of vitamin D for patients with inflammatory bowel diseases: A systematic review</atitle><jtitle>International journal for vitamin and nutrition research</jtitle><date>2024-02</date><risdate>2024</risdate><volume>94</volume><issue>1</issue><spage>54</spage><epage>70</epage><pages>54-70</pages><issn>0300-9831</issn><eissn>1664-2821</eissn><abstract>As vitamin D (VD) plays an essential role in inflammatory bowel diseases (IBD), this systematic review aimed to update the participation of this vitamin in the prevention or remission of these diseases. This review has included studies in MEDLINE–PubMed, EMBASE, and Cochrane databases. The authors have followed PRISMA (Preferred Reporting Items for a Systematic Review and Meta-analysis) guidelines. According to the inclusion and exclusion criteria, twenty-two randomized clinical trials were selected. In total, 1,209 patients were included in this systematic review: 1034 received only VD and 175 received VD in combination with calcium. The average doses of VD supplementation were from oral 400 IU daily to 10,000 IU per kilogram of body weight. Single injection of 300,000 IU of VD was also used. Several studies have shown the crucial role that VD plays in the therapeutic approach of IBD due to its effects on the immune system. It effectively decreased inflammatory cytokines such as TNF-α and IFN-γ (p<0.05) and provided a reduction in disease activity assessed through different scores such as Crohn’s Disease Activity Index (CDAI) (p<0.05) and Ulcerative Colitis Disease Activity Index (UCDAI) (p<0.05). Unfortunately, the available clinical trials are not standardized for of doses and routes of administration. Existing meta-analyses are biased because they compare studies using different doses or treatments in combination with different drugs or supplements such as calcium. Even though VD has crucial effects on inflammatory processes, there is still a need for standardized studies to establish how the supplementation should be performed and the doses to be administered.</abstract><doi>10.1024/0300-9831/a000764</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0003-3159-0982</orcidid><orcidid>https://orcid.org/0000-0001-6006-1321</orcidid><orcidid>https://orcid.org/0000-0002-9930-9694</orcidid><orcidid>https://orcid.org/0000-0002-5035-876X</orcidid><orcidid>https://orcid.org/0000-0002-5716-2444</orcidid><orcidid>https://orcid.org/0000-0003-2445-0332</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0300-9831 |
| ispartof | International journal for vitamin and nutrition research, 2024-02, Vol.94 (1), p.54-70 |
| issn | 0300-9831 1664-2821 |
| language | eng |
| recordid | cdi_crossref_primary_10_1024_0300_9831_a000764 |
| source | Alma/SFX Local Collection |
| title | The use of vitamin D for patients with inflammatory bowel diseases: A systematic review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T05%3A22%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20vitamin%20D%20for%20patients%20with%20inflammatory%20bowel%20diseases:%20A%20systematic%20review&rft.jtitle=International%20journal%20for%20vitamin%20and%20nutrition%20research&rft.au=Matias,%20J%C3%BAlia%20Novaes&rft.date=2024-02&rft.volume=94&rft.issue=1&rft.spage=54&rft.epage=70&rft.pages=54-70&rft.issn=0300-9831&rft.eissn=1664-2821&rft_id=info:doi/10.1024/0300-9831/a000764&rft_dat=%3Ccrossref%3E10_1024_0300_9831_a000764%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |